EMEA-000174-PIP01-07-M03
Key facts
Invented name |
Mozobil
|
Active substance |
Plerixafor
|
Therapeutic area |
Oncology
|
Decision number |
P/0253/2013
|
PIP number |
EMEA-000174-PIP01-07-M03
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Myelosuppression caused by chemotherapy to treat malignant disorders, which requires an autologous haematopoietic stem cell transplant
|
Route(s) of administration |
|
Contact for public enquiries |
Genzyme Europe B.V.
E-mail: eumedinfo@genzyme.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-000174-PIP01-07-M03
|
Compliance opinion date |
26/01/2018
|
Compliance outcome |
positive
|